We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gene Test for Breast Cancer Decreases Cost of Care Nationwide

News   Apr 25, 2019 | Original story from Georgetown Lombardi Comprehensive Cancer Center

 
Gene Test for Breast Cancer Decreases Cost of Care Nationwide

Cancer prognostic tests such as Oncotype DX and MammaPrint appear to lower the cost of breast cancer care in the US. Such tests provide a score based on her tumor's molecular makeup that indicates when a woman can forgo expensive chemotherapy. Credit: Genomic Health.

 
 
Advertisement
 

RELATED ARTICLES

A Step Closer to A Blood Test for Diagnosing Mood Disorders?

News

A new study published in Molecular Psychiatry outlines the development of an RNA biomarker-based blood test for distinguishing how severe an individual's depression is, determining the risk of a patient developing severe depression in the future, determining the risk of future bipolar disorder and tailored medication choices for patients.

READ MORE

Repurposing Drugs To Manage COVID-19 Progression

News

Researchers have used a large-scale human genetics study to identify drug targets important for managing COVID-19 in its early stages.

READ MORE

Scientists Report the Full Assembly of Human Chromosome 8

News

Scientists have reported the full assembly of human chromosome 8. While on the outside this chromosome looks typical, being neither short nor long or distinctive, its DNA content and arrangement are of interest in primate and human evolution, in several immune and developmental disorders, and in chromosome sequencing structure and function generally.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE